# QBREXZA
> **NDA210361** · New Drug Application · Sponsor: JOURNEY · Approved 2018-06-28
## Drug
- **FDA Application Number:** NDA210361
- **Application type:** New Drug Application
- **Brand name:** QBREXZA
- **Generic name:** GLYCOPYRRONIUM
- **Active ingredients:** GLYCOPYRRONIUM TOSYLATE
- **Dosage form:** CLOTH
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** JOURNEY
- **Manufacturer:** Journey Medical Corporation
- **First approval:** 2018-06-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210361)
---
*AI Analytics · CC0 1.0*